期刊文献+

生物相容性高分子基因载体的研究进展 被引量:2

Biocompatible polymers for gene delivery in cancer gene therapy
暂未订购
导出
摘要 基因治疗为各种先天性或后天性疾病(如肿瘤)提供了一种新的治疗方式,因此应用前景广阔。由于裸基因易受到多种因素(如,酶降解、肾滤过作用引起的快速清除、不易被细胞摄取、从内涵体到细胞质的释放不充分等)的影响,应用受到严重限制。要成功的达到基因治疗的目的,开发安全有效的基因传递系统十分必要。随着基因传递系统的日益发展,对所开发的载体的安全性要求也越来越高。本文介绍生物相容性高分子,如壳聚糖、聚氨基酯以及它们的衍生物作为肿瘤基因治疗非病毒高分子载体的一些研究动态。 Gene therapy holds great promise in providing new approaches for the treatment of a large number of inherited and acquired diseases, such as cancer. Yet its widespread application has been restricted by naked genes vulnerable to enzyme degradation, the rapid clearance by renal filtration, the poor cellular uptake and the inefficient escape out of endosome into cytosol. A successful gene therapy mainly relies on the development of an efficient gene delivery system. The safe and efficient delivery of therapeutic genes to host cells and subsequent release in the target compartment in a therapeutic way represents a fundamental obstacle to the clinical success of gene therapy. Here, we summarize the recent researches concerning biocompatible polymers such as chitosan, poly ( amino ester) s and their derivatives as non-viral vectors for cancer gene therapy.
作者 姜虎林
出处 《中国药科大学学报》 CAS CSCD 北大核心 2013年第5期476-481,共6页 Journal of China Pharmaceutical University
关键词 基因治疗 生物相容性高分子 壳聚糖 聚氨基酯 安全性 有效性 gene therapy biocompatible polymer chitosan poly( amino ester) s safety efficacy
  • 相关文献

参考文献43

  • 1Verma IM, Somia N. Gene therapy - promises, problems and pros- pects [ J ]. Nature, 1997,389 (6 648 ) :239 - 242.
  • 2Park TG, Jeong JH, Kim SW. Current status of polymeric gene delivery systems [ J ]. Adv Drug Deliv Rev, 2006,58 ( 4 ) : 467 - 486.
  • 3Kim SS, Garg H, Joshi A, et al. Strategies for targeted nonviral delivery of siRNAs in vivo[J]. Trends Mol Med,2009,15( 11 ) : 491 - 500.
  • 4Ferber D. Gene therapy. Safer and virus-free[J] ? Science,2001, 294(5 547) :1 638 -1 642.
  • 5Boussif O, Lezoualc'h F, Zanta MA, et al. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo : polyethylenimine[ Jl. Proc Natl Acad Sci U S A, 1995,92(16) : 7 297-7 301.
  • 6Godbey WT, Wu KK, Mikos AG. Poly ( ethylenimine ) -mediated gene delivery affects endothelial cell function and viability [ J ]. Biomaterials,2001,22(5) :471 -480.
  • 7Jiang HL, Kim YK, Arote R, et al. Chitosan-graft-polyethyleni- mine as a gene carrier[ J]. J Control Release,2007,117(2) :273 - 280.
  • 8Hunter AC. Molecular hurdles in polyfeetin design and mechanis- tic background to polycation induced cytotoxicity [ J ]. Adv Drug Deliv Rev ,2006 ,58 ( 14 ) : 1 523 - 1 531.
  • 9Moghimi SM, Symonds P, Murray JC, et al. A two-stage poly ( eth- ylenimine)-mediated cytotoxicity:implications for gene transfer/ therapy [ J ]. Mol Ther,2005,11 (6) :990 - 995.
  • 10Jiang HL,Hong SH,Kim YK,et al. Aerosol delivery of spermine- based poly ( amino ester )/Aktl shRNA complexes for lung cancer gene therapy[J]. Int J Pharm,2011,420(2) :256 -265.

同被引文献17

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部